Abstract:A rational design strategy of the novel podophyllum topoisomerase II (Topo II) inhibitors for the synthesis of the esterification and amidation substituted 4′-demethylepipodophyllotoxin (DMEP) derivates was developed in order to discover the potential antitumor prodrug. Firstly, according to the structure–activity relationship, drug combination principle and bioisosterism, the –COO– and the –NH– bond substituents at the 4 position of cycloparaffin would be a great modification direction to improve antitumor activity of 4′-demethylepipodophyllotoxin (DMEP). Secondly, from the prodrug principle view, the esterification and amidation at the C-4 position of DMEP would be two useful structure modifications for improve solubility. Thirdly, from the activity pocket in Topo II-DNA cleavage complex point of view, a series of heterocyclic with pharmacological activity were chosen as module for improving antitumor activity by binding with Topo II. Finally, nine novel esterification and amidation DMEP derivates were designed and synthesized for the potential Topo II inhibitors with the superior biological activity. All the novel compounds exhibited promising in vitro antitumor activity, especially 4-O-(2-pyrazinecarboxylic)-4′-demethylepipodophyllotoxin (compound 1). The antitumor activity of compound 1 against tumor cell line HeLa (i.e., the IC50 value of 0.60±0.20μM), A549 (i.e., the IC50 value of 3.83±0.08μM), HepG2 (i.e., the IC50 value of 1.21±0.05μM), and BGC-823 (i.e., the IC50 value of 4.15±1.13μM) was significantly improved by 66, 16, 12, and 6 times than that of the clinically important podophyllum anticancer drug etoposide (i.e., the IC50 values of 15.32±0.10, 59.38±0.77, 67.25±7.05, and 30.74±5.13μM), respectively. Compound 1 could arrest HeLa cell cycle G2/M and induce apoptosis by strongly diminishing the relaxation reaction of Topo II-DNA decatenation. The correctness of rational drug design was strictly demonstrated by the bioactivity test.

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity

A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell.

Structural Optimizations and Bioevaluation of N-substituted Acridone Derivatives As Strong Topoisomerase II Inhibitors.

Design and Synthesis of the Novel DNA Topoisomerase II Inhibitors: Esterification and Amination Substituted 4'-Demethylepipodophyllotoxin Derivates Exhibiting Anti-Tumor Activity by Activating ATM/ATR Signaling Pathways.

Emerging DNA topoisomerase inhibitors as anticancer drugs

Synthesis and Biological Evaluation of Xanthone Derivatives As Anti-Cancer Agents Targeting Topoisomerase II and DNA

E17 Exerts Anti-Tumor Activity Through Inhibiting Topo II-mediated Chromosomes Condensation in CRC Cells.

Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches

MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II

Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors

A Rational Design Strategy of the Novel Topoisomerase II Inhibitors for the Synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with Antitumor Activity by Diminishing the Relaxation Reaction of Topoisomerase II-DNA Decatenation.

Design and Synthesis of 2-Phenylnaphthalenoids As Inhibitors of DNA Topoisomeraseiiα and Antitumor Agents.

CS1 is a Novel Topoisomerase IIα Inhibitor with Favorable Drug Resistance Profiles.

Identification of potent catalytic inhibitors of human DNA topoisomerase II by structure-based virtual screening.

The Discovery and Optimization of Novel Dual Inhibitors of Topoisomerase Ii and Histone Deacetylase

Synthesis of 2‐phenylnaphthalenoid amide derivatives and their topoisomerase IIα inhibitory and antiproliferative activities

Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs.

Discovery of Indolo[3,2- c]isoquinoline Derivatives as Novel Top1/2 Dual Inhibitors with Orally Efficacious Antitumor Activity and Low Toxicity

A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.

Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives As Nonintercalative Topoisomerase II Catalytic Inhibitors.

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.